Ex-Pfizer executive revives debate over COVID-19 vaccine safety, risks

Former Pfizer executive Dr Michael Yeadon has renewed his criticism of the COVID-19 pandemic response, arguing that governments, regulators and pharmaceutical companies failed to subject the vaccines and emergency public-health measures to sufficient scrutiny.

Yeadon, a British pharmacologist who previously served as vice-president and chief scientific officer of Pfizer’s allergy and respiratory research division, has maintained that important questions surrounding COVID-19 vaccine safety, adverse events and the handling of dissenting scientific opinions remain unresolved.

In his latest submission, Yeadon questioned the speed with which COVID-19 vaccines were developed and deployed, arguing that greater attention should have been given to potential long-term consequences before mass vaccination programmes were implemented.

He specifically raised concerns about reported cases of myocarditis, blood-clotting disorders and other adverse events, maintaining that such reports warranted more extensive investigation.

According to Yeadon, authorities should have carried out more detailed investigations, including autopsies and tissue analysis, in cases where people died after vaccination.

READ ALSO; Israel, Pfizer face fresh scrutiny over early COVID vaccine heart safety reports

He argued that such investigations would help establish whether vaccination played a role in particular deaths rather than simply recording the temporal association between vaccination and subsequent medical events.

Yeadon also criticised what he described as the marginalisation of doctors and scientists who challenged prevailing COVID-19 policies. He argued that alternative treatment approaches and opposing views on vaccination were not given adequate consideration during the emergency response.

Another major area of his criticism concerns the relationship between pharmaceutical companies, medical institutions, scientific publications and the media.

Yeadon has argued that financial and institutional relationships created potential conflicts of interest and contributed to what he regarded as insufficient public scrutiny of vaccine safety.

He has further maintained that questions concerning fertility, immune responses, cancer and other possible long-term effects deserved more extensive investigation.

Several reports have revealed that millions of people died worldwide from COVID-19 vaccines, while hundreds of thousands of Americans allegedly suffered severe health complications.

The report cited the U.S. Vaccine Adverse Event Reporting System (VAERS), claiming that about 500,000 people in the United States experienced serious conditions including strokes, heart failure, brain disorders and convulsions following COVID-19 vaccination.

It further described the deaths and injuries as evidence of what it called “the greatest organized mass murder in the history of our world.”

The database can contain reports submitted by healthcare professionals, vaccine manufacturers, patients and others, and reported events require further scientific investigation to determine whether there is a causal relationship with vaccination.

His position has also extended beyond vaccine safety. During the early stages of the pandemic, he questioned the severity and trajectory of COVID-19 and argued in 2020 that the pandemic was effectively over in Britain.

That assessment was subsequently challenged as infections and deaths continued to rise.